Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company
February 05, 2024 07:50 ET
|
Avicanna Inc.
Exclusive supply agreement for two of Avicanna’s proprietary topical products in the European region Right of first refusal agreement for the Avicanna’s SEDDs capsules in the European region ...
Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil
January 30, 2024 07:30 ET
|
Avicanna Inc.
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna Announces Closing of Non-Brokered Private Placement
December 04, 2023 17:00 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Reports Q3 2023 Results
November 14, 2023 17:00 ET
|
Avicanna Inc.
Acquisition of Medical Cannabis by Shoppers assets leading to the launch of MyMedi.ca.Record revenue of $6.27M, representing an increase of 90% over Q2, and 713% year-over-year.Improvements in...
Avicanna Announces Appointment of Paul Fornazzari to Board of Directors
November 13, 2023 17:30 ET
|
Avicanna Inc.
TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of...
Avicanna To Hold Third Quarter 2023 Earnings Conference Call
November 01, 2023 17:55 ET
|
Avicanna Inc.
TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna Provides Update on the Successful Launch of MyMedi.ca
October 11, 2023 07:30 ET
|
Avicanna Inc.
infrastructure to offer insurance reimbursement services for patients through several private insurance providers and public institutions
Retirement of Chandra Panchal, PhD from the Board of Directors
September 01, 2023 17:30 ET
|
Avicanna Inc.
TORONTO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
Avicanna Reports Q2 2023 Financial Statement
August 15, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units
August 02, 2023 19:50 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...